103-81-1 | 2-Phenylacetamide

Packsize	Purity	Availability	Price	Discounted Price
1g	99%	in stock	$13.00	$9.00
5g	99%	in stock	$15.00	$10.00
25g	99%	in stock	$20.00	$14.00
100g	99%	in stock	$58.00	$40.00
500g	99%	in stock	$215.00	$150.00

Description

• Catalog Number: AB42724
• Chemical Name: 2-Phenylacetamide
• CAS Number: 103-81-1
• Molecular Formula: C8H9NO
• Molecular Weight: 135.1632
• MDL Number: MFCD18449377
• SMILES: NC(=O)Cc1ccccc1
• NSC Number: 1877

Computed Properties

• Complexity: 116
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2
• XLogP3: 0.5

Literature

• Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.

  PloS one 20120101

• Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice.

  PloS one 20120101

• N,N'-Dibenzyl-N,N'-dimethyl-N''-(2-phenyl-acet-yl)phospho-ric triamide.

  Acta crystallographica. Section E, Structure reports online 20111201

• Spilanthes acmella ethanolic flower extract: LC-MS alkylamide profiling and its effects on sexual behavior in male rats.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20111015

• NRPS substrate promiscuity diversifies the xenematides.

  Organic letters 20111007

• Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488.

  ChemMedChem 20111004

• Phenylalanine induces Burkholderia cenocepacia phenylacetic acid catabolism through degradation to phenylacetyl-CoA in synthetic cystic fibrosis sputum medium.

  Microbial pathogenesis 20110901

• Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors.

  Marine biotechnology (New York, N.Y.) 20110801

• Structure-based design, synthesis, and antifungal activity of new triazole derivatives.

  Chemical biology & drug design 20110801

• Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.

  Molecular pharmacology 20110701

• Isolation and characterization of atropisomers of seven-membered-ring benzolactams.

  The Journal of organic chemistry 20110617

• Valine and phenylalanine as precursors in the biosynthesis of alkamides in Acmella radicans.

  Natural product communications 20110601

• Efficacy of Advanced Odomos repellent cream (N, N-diethyl-benzamide) against mosquito vectors.

  The Indian journal of medical research 20110401

• Chemical composition and antioxidant properties of extracts of fresh fruiting bodies of Pleurotus sajor-caju (Fr.) Singer.

  Journal of agricultural and food chemistry 20110323

• Synthesis of new 1,3-oxazolyl-7-chloroquinazolin-4(3H)ones and evaluation of their antimicrobial activities.

  Acta poloniae pharmaceutica 20110101

• SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor.

  PloS one 20110101

• LC-MS profiling of N-alkylamides in Spilanthes acmella extract and the transmucosal behaviour of its main bio-active spilanthol.

  Journal of pharmaceutical and biomedical analysis 20101102

• 2,3-Disubstituted acrylamides as potent glucokinase activators.

  Bioorganic & medicinal chemistry letters 20101001

• Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift.

  Virology 20100930

• Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100701

• Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.

  Bioorganic & medicinal chemistry letters 20100401

• Heterologous expression of leader-less pga gene in Pichia pastoris: intracellular production of prokaryotic enzyme.

  BMC biotechnology 20100101

• 2-(4-Bromo-phen-yl)-N-(2-methoxy-phen-yl)acetamide.

  Acta crystallographica. Section E, Structure reports online 20100101

• Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.

  Bioorganic & medicinal chemistry 20090715

• Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.

  Bioorganic & medicinal chemistry letters 20090615

• N-(3,4-Diethoxy-phen-yl)acetamide.

  Acta crystallographica. Section E, Structure reports online 20090601

• Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide.

  Drug metabolism and disposition: the biological fate of chemicals 20090501

• Phenylethylamide and phenylmethylamide derivatives as new tyrosinase inhibitors.

  Biological & pharmaceutical bulletin 20090201

• Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2.

  BMC microbiology 20090101

• Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.

  Journal of medicinal chemistry 20080612

• Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus.

  Journal of natural products 20080601

• QSAR and pharmacophore analysis on amides against drug-resistant S. aureus.

  SAR and QSAR in environmental research 20080101

• The influence of leukotriene receptors' antagonists on experimentally induced ulcer in rats.

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20080101

• 2,2-Dichloro-N-(2,3-dimethyl-phen-yl)acetamide.

  Acta crystallographica. Section E, Structure reports online 20080101

• Production of enantiomerically pure (S)-beta-phenylalanine and (R)-beta-phenylalanine by penicillin G acylase from Escherichia coli in aqueous medium.

  Biotechnology letters 20071201

• Diastereospecific photocyclization of a isopropylbenzophenone derivative in crystals and the morphological changes.

  The Journal of organic chemistry 20070831

• Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.

  Bioorganic & medicinal chemistry 20070301

• Fluorogenic substrates for lipases, esterases, and acylases using a TIM-mechanism for signal release.

  Biotechnology journal 20070201

• Synthesis and receptor binding studies of 3-substituted piperazine derivatives.

  European journal of medicinal chemistry 20060301

• [Studies on chemical constituents of the brown alga Dictyopteris divaricata].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20060101

• Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice.

  Biochemical pharmacology 20050801

• SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.

  Bioorganic & medicinal chemistry letters 20040906

• Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta.

  Bioorganic & medicinal chemistry letters 20040705

• Mandelamide hydrolase from Pseudomonas putida: characterization of a new member of the amidase signature family.

  Biochemistry 20040622

• Studies on anti-Helicobacter pylori agents. Part 3: A novel, efficacious cephem derivative, FR193879.

  Bioorganic & medicinal chemistry letters 20040517

• Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

  Journal of medicinal chemistry 20040311

• Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.

  Drug metabolism and disposition: the biological fate of chemicals 20040101

• Metabolism of 2-phenylethylamine to phenylacetic acid, via the intermediate phenylacetaldehyde, by freshly prepared and cryopreserved guinea pig liver slices.

  In vivo (Athens, Greece) 20040101

• Bhimamycin A to approximately E and bhimanone: isolation, structure elucidation and biological activity of novel quinone antibiotics from a terrestrial Streptomycete.

  The Journal of antibiotics 20031101

• Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: probing the role of P2 aryloxyprolines with hybrid structures.

  Bioorganic & medicinal chemistry letters 20030818

• Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.

  Journal of medicinal chemistry 20030508

• The scent of age.

  Proceedings. Biological sciences 20030507

• Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling.

  Journal of medicinal chemistry 20030130

• Role of alphaArg145 and betaArg263 in the active site of penicillin acylase of Escherichia coli.

  The Biochemical journal 20020701

• Synthesis and antimicrobial activity of some novel 2-(p-substituted-phenyl)-5-substituted-carbonylaminobenzoxazoles.

  Farmaco (Societa chimica italiana : 1989) 20020301

• Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.

  Journal of medicinal chemistry 20011206

• A chemostat culture as a tool for the improvement of a recombinant E. coli strain over-producing penicillin G acylase.

  Biotechnology and bioengineering 20011005

• An enzyme-labile safety catch linker for synthesis on a soluble polymeric support.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010302

• Substitutions of Thr-103-Ile and Trp-138-Gly in amidase from Pseudomonas aeruginosa are responsible for altered kinetic properties and enzyme instability.

  Molecular biotechnology 20010301

• Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.

  Experimental and clinical cardiology 20010101

• Isolation and characterization of a bacterium possessing a novel aldoxime-dehydration activity and nitrile-degrading enzymes.

  Archives of microbiology 19980801